The Need to Address GI Complications in Transplant Patients
1 in 5 transplant patients suffer from GI complications —impacting recovery and survival1
The most frequent GI complications in renal transplant recipients include1
Oral lesions
Esophagitis
Peptic ulcer
Diarrhea
Colon hemorrhage
or perforation
GI Side Effects Disrupt Treatment in
Nearly 40% of Patients—Putting Transplants at Risk2
Effect on immunosuppressant dose following GI complications in renal transplant patients2
Treatment Interruptions Following GI Side Effects
Could Significantly Increase the Risk of Graft Failure 3
Increased risk of graft failure following MMF dose discontinuation in renal transplant patients3
Optimizing immunosuppressive treatment to address
GI side effects early can save transplants—and lives
is an enteric-coated formulation of mycophenolate sodium, designed to help reduce GI side effects while maintaining therapeutic equivalence with MMF.4
Protect Transplants. Prevent GI Complications. Choose Myfortic®!
Abbreviations: MMF: mycophenolate mofetil; GI: gastrointestinal
References: 1. Ponticelli C, Passerini P. Transplant Int. 2005;18(6):643-650; 2.Gil-Vernet S, et al. Transplant Proc. 2007;39(7):2190-2193; 3. Hardinger KL, et al. Transplantation.2004;78(2):84-85; 4. Salvadori M, et al. Am J Transplant. 2004;4(2):231-236.
20 Pasir Panjang Road #10-25/28 Mapletree Business City (West Tower) Singapore 117439
Phone: +65 6722 6010
FOR HEALTHCARE PROFESSIONALS ONLY
APPROVAL CODE
